Oncology Institute Inc reports results for the quarter ended in September - Earnings Summary

Oncology Institute

09/11/2022 22:39

* Oncology Institute Inc  TOI.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 18 cents per share.
    * Revenue was $64.98 million​; analysts expected $68.95
million. 
    * Oncology Institute Inc's reported EPS for the quarter was
a loss
of 3 cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Oncology Institute Inc shares had fallen by 30.0% this
quarter and lost 66.8% so far this year.
    * The company reported a quarterly loss of $2.67 million.
    * Wall Street's median 12-month price target for Oncology
Institute Inc is $8.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 10:39 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.18          -0.25          Missed